Extended-Interval Gentamicin Dosing for Pulmonic Tularemia

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Medicine

Background:

• Francisella tularensis causes tularemia, a rare zoonotic disease with diverse clinical presentations.
• Diagnosis relies on serology or PCR, with streptomycin historically being the primary treatment.
• Gentamicin is now preferred due to availability and a better safety profile, especially with extended-interval dosing.

Observation:

• This case series details four patients diagnosed with pulmonic tularemia.
• All patients presented with symptoms indicative of lung involvement.

Findings:

• Pulmonic tularemia was successfully treated in all four patients using extended-interval gentamicin dosing.
• No instances of treatment failure or disease relapse were observed in the case series.

Implications:

• Extended-interval gentamicin demonstrates effectiveness and safety for treating pulmonic tularemia.
• This dosing strategy may become a valuable option in tularemia management, particularly in resource-limited settings.
• Further research is warranted to confirm these findings in larger patient cohorts.